Next Article in Journal
Combination of [177Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model
Next Article in Special Issue
A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s Disease
Previous Article in Journal
Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities
Previous Article in Special Issue
Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(6), 1283; https://doi.org/10.3390/pharmaceutics14061283
Action Date Notes Link
article pdf uploaded. 16 June 2022 15:29 CEST Version of Record https://www.mdpi.com/1999-4923/14/6/1283/pdf-vor
article xml file uploaded 20 June 2022 11:57 CEST Original file -
article xml uploaded. 20 June 2022 11:57 CEST Update https://www.mdpi.com/1999-4923/14/6/1283/xml
article pdf uploaded. 20 June 2022 11:57 CEST Updated version of record https://www.mdpi.com/1999-4923/14/6/1283/pdf
article html file updated 20 June 2022 11:59 CEST Original file -
article html file updated 12 August 2022 20:50 CEST Update https://www.mdpi.com/1999-4923/14/6/1283/html
Back to TopTop